Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-106644
Filing Date
2025-08-11
Accepted
2025-08-11 17:07:32
Documents
87
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gyre-20250630.htm   iXBRL 10-Q 3728795
2 EX-31.1 gyre-ex31_1.htm EX-31.1 19737
3 EX-31.2 gyre-ex31_2.htm EX-31.2 19623
4 EX-32.1 gyre-ex32_1.htm EX-32.1 15610
5 EX-32.2 gyre-ex32_2.htm EX-32.2 15479
  Complete submission text file 0000950170-25-106644.txt   15575565

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gyre-20250630.xsd EX-101.SCH 1665343
90 EXTRACTED XBRL INSTANCE DOCUMENT gyre-20250630_htm.xml XML 3644988
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 251202918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)